Exploring the Potential Longevity Applications of ChatGPT and Rapamycin

Explore Potential Rapamycin Applications with ChatGPT

In 2020, I participated in the private beta testing of Open AI’s Generative Pretrained Transformer 3(GPT-3), an older version of ChatGPT. In November 2022 I began experimenting with ChatGPT. Over the past two years, I have been evaluating how this technology could be used by me. I am also interested in how scientists and academics are using this new technology to make meaningful contributions to educational work and research.

Recent research showed that ChatGPT could pass the US Medical Licensing Exam with no special training and demonstrated a high degree of insight when explaining. These results indicate that ChatGPT could be useful in medical education.

Last week, I published my first article on ChatGPT. The article entitled \”How The Evolution Of AI In Healthcare Aligns with Thomas Kuhn’s Structure\” has been viewed more than 13,000 times and received over

Source:
https://www.linkedin.com/pulse/exploring-potential-longevity-applications-rapamycin-colangelo/

Leave a Reply

Your email address will not be published. Required fields are marked *